Passage Bio's total assets for Q3 2025 were $74.16M, a decrease of -6.36% from the previous quarter. PASG total liabilities were $43.04M for the fiscal quarter, a 5.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.